Walgreens Boots Alliance Inc (NASDAQ:WBA)‘s stock had its “outperform” rating reiterated by equities researchers at Robert W. Baird in a research report issued on Monday. They currently have a $96.00 price objective on the pharmacy operator’s stock. Robert W. Baird’s price objective would indicate a potential upside of 14.89% from the stock’s previous close.
A number of other equities research analysts have also recently weighed in on WBA. Leerink Swann set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Sunday, January 8th. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Deutsche Bank AG set a $92.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Saturday, January 21st. Atlantic Securities raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 target price on the stock in a report on Monday, February 6th. Finally, Evercore ISI reaffirmed a “buy” rating and set a $93.00 target price on shares of Walgreens Boots Alliance in a report on Tuesday, January 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have given a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $91.56.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up 0.71% on Monday, hitting $83.56. 2,410,041 shares of the stock traded hands. The company’s 50 day moving average is $84.84 and its 200 day moving average is $83.05. The stock has a market cap of $90.20 billion, a price-to-earnings ratio of 22.11 and a beta of 1.20. Walgreens Boots Alliance has a one year low of $75.74 and a one year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.01. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The business had revenue of $28.50 billion for the quarter. During the same quarter in the prior year, the firm earned $1.03 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance will post $5.00 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, March 10th. Investors of record on Wednesday, February 15th were paid a $0.375 dividend. The ex-dividend date of this dividend was Monday, February 13th. This represents a $1.50 dividend on an annualized basis and a yield of 1.80%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.68%.
In related news, COO Ornella Barra purchased 124,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 7th. The shares were purchased at an average price of $80.93 per share, with a total value of $10,035,320.00. Following the purchase, the chief operating officer now owns 1,690,336 shares of the company’s stock, valued at approximately $136,798,892.48. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Janice M. Babiak purchased 600 shares of the company’s stock in a transaction that occurred on Thursday, February 2nd. The stock was bought at an average cost of $80.68 per share, for a total transaction of $48,408.00. Following the purchase, the director now directly owns 600 shares in the company, valued at approximately $48,408. The disclosure for this purchase can be found here. Company insiders own 13.50% of the company’s stock.
Large investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Walgreens Boots Alliance by 35.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 39,319,406 shares of the pharmacy operator’s stock worth $3,169,931,000 after buying an additional 10,206,621 shares during the last quarter. Norges Bank acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $649,813,000. Nordea Investment Management AB raised its stake in shares of Walgreens Boots Alliance by 4,480.8% in the third quarter. Nordea Investment Management AB now owns 7,453,892 shares of the pharmacy operator’s stock worth $600,933,000 after buying an additional 7,291,172 shares during the last quarter. Viking Global Investors LP raised its stake in shares of Walgreens Boots Alliance by 562.8% in the fourth quarter. Viking Global Investors LP now owns 7,899,951 shares of the pharmacy operator’s stock worth $653,800,000 after buying an additional 6,708,040 shares during the last quarter. Finally, Lazard Asset Management LLC raised its stake in shares of Walgreens Boots Alliance by 138.3% in the third quarter. Lazard Asset Management LLC now owns 7,680,077 shares of the pharmacy operator’s stock worth $619,166,000 after buying an additional 4,457,421 shares during the last quarter. Hedge funds and other institutional investors own 59.98% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.